"10.1371_journal.pone.0005254","plos one","2009-04-23T00:00:00Z","Michele D Spring; James F Cummings; Christian F Ockenhouse; Sheetij Dutta; Randall Reidler; Evelina Angov; Elke Bergmann-Leitner; V Ann Stewart; Stacey Bittner; Laure Juompan; Mark G Kortepeter; Robin Nielsen; Urszula Krzych; Ev Tierney; Lisa A Ware; Megan Dowler; Cornelus C Hermsen; Robert W Sauerwein; Sake J de Vlas; Opokua Ofori-Anyinam; David E Lanar; Jack L Williams; Kent E Kester; Kathryn Tucker; Meng Shi; Elissa Malkin; Carole Long; Carter L Diggs; Lorraine Soisson; Marie-Claude Dubois; W Ripley Ballou; Joe Cohen; D Gray Heppner","United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative, Bethesda, Maryland, United States of America; Department of Medical Microbiology, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; GlaxoSmithKline Biologicals, Rixensart, Belgium; Statistics Collaborative, Incorporated, Washington D. C., United States of America; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Malaria Vaccine Development Program, United States Agency for International Development, Washington D. C., United States of America","Conceived and designed the experiments: MS JFC CFO SD ET CH RWS SJdV DL KEK CD LS WRB JC DGHJFF. Performed the experiments: MS JFC CFO SD RR EA ESBL VAS SB LJ MK RN UK LAW MD CH RWS SJdV DL JW CAL. Analyzed the data: MS CH RWS SJdV KT MS. Contributed reagents/materials/analysis tools: SD EA ESBL VAS UK OOA DL JW EMM CAL MCD. Wrote the paper: MS.","SD, DL, LW and JC have patent interests in the described vaccine. OOA, MCD, JC and WRB are employees of GlaxoSmithKline Biologicals, the manufacturer of the described Adjuvant Systems at the time of the study. ET and EM were employees of PATH MVI, which provided funding for the study.","2009","04","Michele D Spring","MDS",33,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
